Garrison Point Advisors, LLC Bristol Myers Squibb CO Transaction History
Garrison Point Advisors, LLC
- $154 Million
- Q1 2024
A detailed history of Garrison Point Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Garrison Point Advisors, LLC holds 17,470 shares of BMY stock, worth $698,625. This represents 0.61% of its overall portfolio holdings.
Number of Shares
17,470
Previous 17,870
2.24%
Holding current value
$698,625
Previous $916,000
3.38%
% of portfolio
0.61%
Previous 0.65%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,555Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.44 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.5 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.66 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.55 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.81 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $85B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...